OpenAI plans to back a competitor to Elon Musk’s Neuralink in the brain-computer interface market, the Financial Times reported.
Merge Labs aims to raise $250 million for a valuation of $850 million, with much of the funding coming from the maker of ChatGPT, sources told the news outlet. OpenAI co-founder Sam Altman would reportedly co-found the new company but not run it day to day. OpenAI declined to comment to the publication.
Neuralink most recently raised $650 million at a $9 billion valuation, and has received funding from Mr. Altman, according to the Aug. 12 story. Mr. Musk’s company has been implanting brain chips in patients at U.S. hospitals, including a paralyzed man at University of Miami Health System who can now control his smartphone and computer with his thoughts.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
